My transition toward trans awareness.
I recall when a colleague told me in 2014 that some transgender women advocates were unhappy with iPrEx. I was surprised and disappointed. Since the study was conceived in 2004, I had struggled to include trans women for so many reasons and against so many...
“Campos seeks funds for PrEP access” – Comments prepared by Robert Grant for the San Francisco Board of Supervisors
I am Robert Grant, an Investigator at the Gladstone Institutes and Professor of Medicine at UCSF. I led some of the pivotal studies of pre-exposure prophylaxis or PrEP, leading to FDA approval in 2012 and CDC and WHO recommendations in May and June of 2014. We know...
Intentions and fear before the rise of PrEP users
I am a physician, with some training in a variety of fields, who by accident found myself leading a series of clinical trials of pre-exposure prophylaxis, or PREP, including the iPREX trial for gay men and trans women, and the ADAPT trial of non-daily PREP. My...